A review of emerging IL-17 inhibitors in the treatment of psoriasis focusing on preclinical through phase II studies
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A review of emerging IL-17 inhibitors in the treatment of psoriasis focusing on preclinical through phase II studies
Authors
Keywords
-
Journal
EXPERT OPINION ON INVESTIGATIONAL DRUGS
Volume 25, Issue 11, Pages 1337-1344
Publisher
Informa UK Limited
Online
2016-09-30
DOI
10.1080/13543784.2016.1237502
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Development of a Topical Treatment for Psoriasis Targeting RORγ: From Bench to Skin
- (2016) Susan H. Smith et al. PLoS One
- An inflammatory triangle in psoriasis: TNF, type I IFNs and IL-17
- (2015) Lynda Grine et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Genetics of Psoriasis
- (2015) Satveer K. Mahil et al. DERMATOLOGIC CLINICS
- Protective effect of a germline, IL-17-neutralizing antibody in murine models of autoimmune inflammatory disease
- (2015) Kiran Dallenbach et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- In vivoregulation of gene expression and T helper type 17 differentiation by RORγt inverse agonists
- (2015) Jill Skepner et al. IMMUNOLOGY
- Human mast cells are major IL-22 producers in patients with psoriasis and atopic dermatitis
- (2015) Shunya Mashiko et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Interleukin-17 and innate immunity in infections and chronic inflammation
- (2015) Natasa Isailovic et al. JOURNAL OF AUTOIMMUNITY
- Comparison of ixekizumab with etanercept or placebo in moderate-to-severe psoriasis (UNCOVER-2 and UNCOVER-3): results from two phase 3 randomised trials
- (2015) Christopher E M Griffiths et al. LANCET
- Discovery and characterization of COVA322, a clinical-stage bispecific TNF/IL-17A inhibitor for the treatment of inflammatory diseases
- (2015) Michela Silacci et al. mAbs
- IL-12 and IL-23 cytokines: from discovery to targeted therapies for immune-mediated inflammatory diseases
- (2015) Michele W L Teng et al. NATURE MEDICINE
- Phase 3 Studies Comparing Brodalumab with Ustekinumab in Psoriasis
- (2015) Mark Lebwohl et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ursolic acid ameliorates autoimmune arthritis via suppression of Th17 and B cell differentiation
- (2014) Seung-ye Baek et al. ACTA PHARMACOLOGICA SINICA
- Small-Molecule RORγt Antagonists Inhibit T Helper 17 Cell Transcriptional Network by Divergent Mechanisms
- (2014) Sheng Xiao et al. IMMUNITY
- The role of IL-17 in psoriasis
- (2014) Mona Malakouti et al. JOURNAL OF DERMATOLOGICAL TREATMENT
- Total skin clearance results in improvements in health-related quality of life and reduced symptom severity among patients with moderate to severe psoriasis
- (2014) Hema N. Viswanathan et al. JOURNAL OF DERMATOLOGICAL TREATMENT
- Pharmacologic Inhibition of ROR t Regulates Th17 Signature Gene Expression and Suppresses Cutaneous Inflammation In Vivo
- (2014) J. Skepner et al. JOURNAL OF IMMUNOLOGY
- Secukinumab in Plaque Psoriasis — Results of Two Phase 3 Trials
- (2014) Richard G. Langley et al. NEW ENGLAND JOURNAL OF MEDICINE
- IL-17 Induces an Expanded Range of Downstream Genes in Reconstituted Human Epidermis Model
- (2014) Andrea Chiricozzi et al. PLoS One
- Characterization of Innate Lymphoid Cells in Human Skin and Blood Demonstrates Increase of NKp44+ ILC3 in Psoriasis
- (2013) Federica Villanova et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- The IL-23/T17 pathogenic axis in psoriasis is amplified by keratinocyte responses
- (2013) Michelle A. Lowes et al. TRENDS IN IMMUNOLOGY
- Psoriasis: Evolving treatment for a complex disease
- (2012) J. VILLASENOR-PARK et al. CLEVELAND CLINIC JOURNAL OF MEDICINE
- Rorγt+ innate lymphocytes and γδ T cells initiate psoriasiform plaque formation in mice
- (2012) Stanislav Pantelyushin et al. JOURNAL OF CLINICAL INVESTIGATION
- Ursolic Acid Suppresses Interleukin-17 (IL-17) Production by Selectively Antagonizing the Function of RORγt Protein
- (2011) Tao Xu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Mast Cells and Neutrophils Release IL-17 through Extracellular Trap Formation in Psoriasis
- (2011) A. M. Lin et al. JOURNAL OF IMMUNOLOGY
- Digoxin and its derivatives suppress TH17 cell differentiation by antagonizing RORγt activity
- (2011) Jun R. Huh et al. NATURE
- Signal transduction pathways and transcriptional regulation in Th17 cell differentiation
- (2010) Kiyoshi Hirahara et al. CYTOKINE & GROWTH FACTOR REVIEWS
- IL-23-Mediated Psoriasis-Like Epidermal Hyperplasia Is Dependent on IL-17A
- (2010) H. L. Rizzo et al. JOURNAL OF IMMUNOLOGY
- Integrative Responses to IL-17 and TNF-α in Human Keratinocytes Account for Key Inflammatory Pathogenic Circuits in Psoriasis
- (2010) Andrea Chiricozzi et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Psoriasis
- (2009) Frank O. Nestle et al. NEW ENGLAND JOURNAL OF MEDICINE
- Lymphoid tissue inducer–like cells are an innate source of IL-17 and IL-22
- (2008) Hiroaki Takatori et al. JOURNAL OF EXPERIMENTAL MEDICINE
- A critical function for transforming growth factor-β, interleukin 23 and proinflammatory cytokines in driving and modulating human TH-17 responses
- (2008) Elisabetta Volpe et al. NATURE IMMUNOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More